A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies-Reference-Cited by-同舟云学术

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies

Published:2023-03 Issue:3 Volume:4 Page:100961
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Lameris Roeland^ORCID,Ruben Jurjen M.,Iglesias-Guimarais Victoria,de Jong Milon,Veth Myrthe,van de Bovenkamp Fleur S.,de Weerdt Iris,Kater Arnon P.,Zweegman Sonja,Horbach Sjeng,Riedl Thilo,Winograd Benjamin,Roovers Rob C.,Adang Anton E.P.,de Gruijl Tanja D.,Parren Paul W.H.I.,van der Vliet Hans J.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. T cell-engaging therapies - BiTEs and beyond;Goebeler;Nat. Rev. Clin. Oncol.,2020

2. Bispecific antibodies: a mechanistic review of the pipeline;Labrijn;Nat. Rev. Drug Discov.,2019

3. CAR-T cells and BiTEs in solid tumors: challenges and perspectives;Edeline;J. Hematol. Oncol.,2021

4. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N. Engl;Nathan;N. Engl. J. Med.,2021

5. Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies;Kauer;J. Immunother. cancer,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developability considerations for bispecific and multispecific antibodies;mAbs;2024-08-27

2. Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells;Frontiers in Immunology;2024-07-31

3. Camelid‐derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents;European Journal of Immunology;2024-05-28

4. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy;Frontiers in Immunology;2024-03-21

5. Leukemia cancer cells and immune cells derived‐exosomes: Possible roles in leukemia progression and therapy;Cell Biochemistry and Function;2024-02-29